filipin has been researched along with lovastatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiskin, AM; Madden, EA; Melnykovych, G | 1 |
| Thyberg, J | 1 |
| Ahnert-Hilger, G; Herrmann, A; Hinz, B; Hollmann, S; Mitter, D; Ohm, TG; Reisinger, C; Treiber-Held, S; Yelamanchili, SV | 1 |
| Hering, H; Lin, CC; Sheng, M | 1 |
| Distl, R; Glöckner, F; Meske, V; Ohm, TG; Schönheit, B; Tamanai, M; Treiber-Held, S | 1 |
| Borchmann, P; Engert, A; Hansen, HP; Kallen, KJ; Lange, H; von Strandmann, EP; von Tresckow, B | 1 |
| Gniadecki, R | 1 |
| Bang, B; Gajkowska, B; Gniadecki, R | 1 |
| Arias, C; Ferrera, P; Mercado-Gómez, O; Silva-Aguilar, M; Valverde, M | 1 |
| Bee, JW; Bernstone, L; Carter, GC; Harder, T; James, W; Sangani, D | 1 |
| Feng, X; Luo, J; Rolfs, A; Yang, F | 1 |
| Hou, S; Lei, H; Li, Q; Liu, F; Liu, H; Liu, S; Wang, D; Wang, S; Wang, T; Wu, Y; Xu, L; Zaky, MY; Zhang, J; Zhang, Y; Zou, K; Zou, L | 1 |
12 other study(ies) available for filipin and lovastatin
| Article | Year |
|---|---|
Compactin (ML-236B) reduces the content of filipin-cholesterol complexes in the plasma membrane of chronic lymphocytic leukemia cells.
Topics: Anticholesteremic Agents; B-Lymphocytes; Cell Membrane; Cells, Cultured; Cholesterol; Filipin; Freeze Fracturing; Humans; Kinetics; Leukemia, Lymphoid; Lovastatin; Membrane Lipids; Microscopy, Electron; Naphthalenes; Polyenes | 1984 |
Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes.
Topics: Animals; Aorta; beta-Cyclodextrins; Caveolae; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cyclodextrins; Filipin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indicators and Reagents; Lovastatin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenotype; Rats; Rats, Sprague-Dawley | 2002 |
The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content.
Topics: Animals; Anticholesteremic Agents; Brain; CHO Cells; Cholesterol; Cricetinae; Cyclodextrins; Detergents; Filipin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Membrane Proteins; Membranes; Mice; Mice, Inbred BALB C; Niemann-Pick Diseases; Octoxynol; Protein Transport; R-SNARE Proteins; Rats; Solubility; Synaptic Vesicles; Synaptophysin; Up-Regulation | 2003 |
Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability.
Topics: Animals; Brain Chemistry; Carrier Proteins; Cell Membrane; Cells, Cultured; Cholesterol; Dendrites; Detergents; Enzyme Inhibitors; Filipin; Fumonisins; Intracellular Signaling Peptides and Proteins; Lovastatin; Membrane Microdomains; Nerve Tissue Proteins; Neurons; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Sphingolipids; Subcellular Fractions; Synapses | 2003 |
Cholesterol and tau protein--findings in Alzheimer's and Niemann Pick C's disease.
Topics: Acyl Coenzyme A; Alzheimer Disease; Analysis of Variance; Animals; Anticholesteremic Agents; Astrocytes; Blotting, Western; Brain Chemistry; Calcium; Cerebral Cortex; Cholesterol; Dextrans; Drug Interactions; Filipin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Hybridization; Intracellular Signaling Peptides and Proteins; Lovastatin; Mevalonic Acid; Mice; Mice, Inbred BALB C; Mice, Transgenic; Microglia; Microtubules; Neurofibrillary Tangles; Neurons; Niemann-Pick C1 Protein; Niemann-Pick Diseases; Proteins; rho GTP-Binding Proteins; RNA, Messenger; tau Proteins; Tubulin | 2003 |
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.
Topics: ADAM Proteins; ADAM17 Protein; Anticholesteremic Agents; beta-Cyclodextrins; Cell Line, Tumor; Cholesterol; Cholesterol Oxidase; Cyclodextrins; Detergents; Filipin; Humans; Ki-1 Antigen; Lovastatin; Membrane Microdomains; Metalloendopeptidases; Metalloproteases; Octoxynol; Solubility; Tissue Inhibitor of Metalloproteinase-3 | 2004 |
Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis.
Topics: Apoptosis; beta-Cyclodextrins; Cell Line; Cholesterol; Cholesterol Oxidase; Cyclodextrins; Dose-Response Relationship, Drug; fas Receptor; Filipin; Humans; Keratinocytes; Ligands; Lovastatin; Membrane Fluidity; Membrane Microdomains | 2004 |
Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes.
Topics: Apoptosis; beta-Cyclodextrins; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cholesterol; Cholesterol Oxidase; Detergents; Enzyme-Linked Immunosorbent Assay; Filipin; Humans; In Situ Nick-End Labeling; Keratinocytes; Lipids; Lovastatin; Membrane Microdomains; Microscopy, Confocal; Microscopy, Electron; Microscopy, Fluorescence; Time Factors | 2005 |
Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Cell Line, Tumor; Cell Survival; Cholesterol; Filipin; Humans; Lipid Peroxidation; Lovastatin; Mice; Neuroblastoma; Oxidative Stress; Reactive Oxygen Species | 2008 |
HIV entry in macrophages is dependent on intact lipid rafts.
Topics: Antimetabolites; beta-Cyclodextrins; Cells, Cultured; Filipin; HIV-1; Humans; Lovastatin; Macrophages; Membrane Microdomains; Nystatin; Virus Attachment; Virus Internalization | 2009 |
Lovastatin promotes myelin formation in NPC1 mutant oligodendrocytes.
Topics: Animals; Animals, Newborn; Anticholesteremic Agents; Antiviral Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Disease Models, Animal; Filipin; Gene Expression Regulation; Lovastatin; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mutation; Myelin Proteins; Myelin Sheath; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oligodendrocyte Transcription Factor 2; Oligodendroglia | 2018 |
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cholesterol; Drug Synergism; Endocytosis; Female; Filipin; Humans; Lapatinib; Lovastatin; Mice, Nude; Models, Biological; Protein Kinase Inhibitors; Proteolysis; Receptor, ErbB-2; Xenograft Model Antitumor Assays | 2019 |